Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BioSniper serves as a research platform tailored for equity analysts, investors, and professionals in the life sciences sector. Users can articulate their research or investment ideas in straightforward language, and the platform then organizes this input into a systematic workflow that includes various screenings, checks by specialized agents, scoring mechanisms, blocking protocols, and gates for evidence. It conducts searches across seven categories of public sources, which encompass SEC EDGAR filings along with insider trading data, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. The platform ensures that findings are linked to their source records, with any gaps or discrepancies in evidence flagged as unknown instead of making assumptions; it also provides the source and applicable dates when they are available. Furthermore, BioSniper includes a complimentary public calendar for biotech events, an SEC cash runway calculator, and an open-source toolkit in Python for users to leverage. In addition to these features, the platform aims to enhance the decision-making process for its users by providing comprehensive access to relevant data.
Description
Gain is an advanced private markets intelligence platform built to streamline deal sourcing, research, and execution for financial professionals. It delivers investment-grade data that connects companies, investors, deals, and advisors into a single, unified ecosystem. With coverage spanning hundreds of thousands of transactions and thousands of market participants, Gain provides deep insights into private markets. The platform allows users to quickly screen entire industries, identify opportunities, and evaluate potential investments. By replacing multiple standalone tools, Gain simplifies workflows and improves operational efficiency. It is widely used by private equity firms, M&A advisors, consultants, and corporate development teams. Gain also offers proprietary insights and research reports that help users stay ahead of market trends. Its interconnected data structure enables better decision-making by providing context across multiple data points. The platform is trusted by organizations managing over a trillion dollars in private capital. Overall, Gain empowers dealmakers to work faster, smarter, and with greater confidence.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
$39/month
A free plan is available. Researcher costs $39/month, and Analyst costs $79/month. Monthly AI credit allowances are 200, 3,000, and 10,000 for Free, Researcher, and Analyst, respectively; the plans also differ in research and customization features.
Free Trial
No
Free Version
Yes
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
BioSniper
Founded
2024
Country
United States
Website
biosniper.co
Vendor Details
Company Name
Gain
Founded
2018
Country
United States
Website
www.gain.ai/